Gelesis Holdings (Gelesis Holdings) FCF Yield % : -32,681.82 (As of Jun. 22, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Gelesis Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Gelesis Holdings's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Gelesis Holdings's FCF Yield % for today is -32,681.82%.

The historical rank and industry rank for Gelesis Holdings's FCF Yield % or its related term are showing as below:

GLSWQ' s FCF Yield % Range Over the Past 10 Years
Min: -52792.51 Med: -698.35 Max: -15.95
Current: -32681.82

During the past 2 years, the highest FCF Yield % of Gelesis Holdings was -15.95%. The lowest was -52792.51%. And the median was -698.35%.

GLSWQ's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.395 vs GLSWQ: -32681.82

Gelesis Holdings's FCF Margin % for the quarter that ended in Jun. 2023 was 54.11%.

Gelesis Holdings FCF Yield % Historical Data

The historical data trend for Gelesis Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gelesis Holdings FCF Yield % Chart

Gelesis Holdings Annual Data

Trend

Dec21

Dec22

FCF Yield %

Gelesis Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
FCF Yield %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Gelesis Holdings's FCF Yield %

For the Biotechnology subindustry, Gelesis Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's FCF Yield % falls into.

Gelesis Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Gelesis Holdings's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-86.848	/
	=	N/A%

Gelesis Holdings's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.599	*	4	/
	=	N/A%

Gelesis Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Gelesis Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Gelesis Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gelesis Holdings (Gelesis Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gelesis Holdings Inc (OTCPK:GLSWQ) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

501 Boylston Street, Suite 6102, Boston, MA, USA, 02116

Website

https://www.gelesis.com

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.